Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95


Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.

Karthik GM, Rantalainen M, Stålhammar G, Lövrot J, Ullah I, Alkodsi A, Ma R, Wedlund L, Lindberg J, Frisell J, Bergh J, Hartman J.

BMC Cancer. 2017 Nov 29;17(1):802. doi: 10.1186/s12885-017-3815-2.


20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.


Breast cancer in young women and prognosis: How important are proliferation markers?

Fredholm H, Magnusson K, Lindström LS, Tobin NP, Lindman H, Bergh J, Holmberg L, Pontén F, Frisell J, Fredriksson I.

Eur J Cancer. 2017 Oct;84:278-289. doi: 10.1016/j.ejca.2017.07.044. Epub 2017 Aug 29.


Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).

Fu M, Ahrenmark U, Berglund S, Lindholm CJ, Lehto A, Broberg AM, Tasevska-Dinevska G, Wikstrom G, Ågard A, Andersson B; All investigators of the HR-HF study.

Clin Res Cardiol. 2017 Dec;106(12):960-973. doi: 10.1007/s00392-017-1146-6. Epub 2017 Aug 9.


Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Rydén L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists’ Group.

BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.


Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.

Ma R, Karthik GM, Lövrot J, Haglund F, Rosin G, Katchy A, Zhang X, Viberg L, Frisell J, Williams C, Linder S, Fredriksson I, Hartman J.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-14. doi: 10.1093/jnci/djw236.


Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.

Zetterlund LH, Frisell J, Zouzos A, Axelsson R, Hatschek T, de Boniface J, Celebioglu F.

Breast Cancer Res Treat. 2017 May;163(1):103-110. doi: 10.1007/s10549-017-4164-1. Epub 2017 Feb 21.


Vägen till bröstbevarande kirurgi och bort från axillutrymning.

Bergkvist L, Frisell J, Sackey H.

Lakartidningen. 2017 Feb 14;114. pii: EDWR. Swedish. No abstract available.


Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.

Zetterlund L, Celebioglu F, Axelsson R, de Boniface J, Frisell J.

Breast Cancer Res Treat. 2017 May;163(1):93-101. doi: 10.1007/s10549-017-4163-2. Epub 2017 Feb 17.


Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.

de Boniface J, Frisell J, Bergkvist L, Andersson Y; Swedish Breast Cancer Group and the Swedish Society of Breast Surgery.

Br J Surg. 2017 Feb;104(3):238-247. doi: 10.1002/bjs.10411. Epub 2017 Jan 4.


Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

Rantalainen M, Klevebring D, Lindberg J, Ivansson E, Rosin G, Kis L, Celebioglu F, Fredriksson I, Czene K, Frisell J, Hartman J, Bergh J, Grönberg H.

Sci Rep. 2016 Nov 30;6:38037. doi: 10.1038/srep38037.


The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.

Sackey H, Hui M, Czene K, Verkooijen H, Edgren G, Frisell J, Hartman M.

Breast Cancer Res. 2016 Oct 18;18(1):105.


Long-term outcome in young women with breast cancer: a population-based study.

Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, Bergh J, Holmberg L, Pontén F, Frisell J, Fredriksson I.

Breast Cancer Res Treat. 2016 Nov;160(1):131-143. Epub 2016 Sep 13.


Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision.

Zetterlund L, Gabrielson S, Axelsson R, de Boniface J, Frisell J, Olsson A, Celebioglu F.

Breast. 2016 Dec;30:32-38. doi: 10.1016/j.breast.2016.08.006. Epub 2016 Sep 3.


Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.

Li J, Ivansson E, Klevebring D, Tobin NP, Lindström LS, Holm J, Prochazka G, Cristando C, Palmgren J, Törnberg S, Humphreys K, Hartman J, Frisell J, Rantalainen M, Lindberg J, Hall P, Bergh J, Grönberg H, Czene K.

Clin Cancer Res. 2017 May 15;23(10):2584-2592. doi: 10.1158/1078-0432.CCR-16-0967. Epub 2016 Sep 1.


Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.

Nyström L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J.

J Med Screen. 2017 Mar;24(1):34-42. doi: 10.1177/0969141316648987. Epub 2016 Jul 7.


Population-based analysis of colorectal cancer risk after oophorectomy.

Segelman J, Lindström L, Frisell J, Lu Y.

Br J Surg. 2016 Jun;103(7):908-15. doi: 10.1002/bjs.10143. Epub 2016 Apr 26.


Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers.

Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johansson U, Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Mátrai Z, Sávolt Á, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H.

Acta Oncol. 2016 Jun;55(6):712-9. doi: 10.3109/0284186X.2015.1136751. Epub 2016 Feb 15.


Increased risk of colorectal cancer in patients diagnosed with breast cancer in women.

Lu Y, Segelman J, Nordgren A, Lindström L, Frisell J, Martling A.

Cancer Epidemiol. 2016 Apr;41:57-62. doi: 10.1016/j.canep.2016.01.006. Epub 2016 Jan 27.


Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.

Sackey H, Johansson H, Sandelin K, Liljegren G, MacLean G, Frisell J, Brandberg Y.

Eur J Surg Oncol. 2015 Apr;41(4):577-84. doi: 10.1016/j.ejso.2014.12.006. Epub 2015 Jan 13.


Supplemental Content

Loading ...
Support Center